Saturday, May 31, 2008
Westin Chicago River North
Grand Ballroom
River Level II
Chicago, Illinois
This live satellite symposium will feature several engaging talks on the state of the art in the application of research on receptor-mediated signaling into clinical practice. Topics to be addressed include the role of EGFR targeting in gastrointestinal cancers, the emerging role of multitargeted TKIs in a variety of cancers, and the importance of the tumor microenvironment as a target for anticancer therapy.
Not an official event of the ASCO Annual Meeting. Not sponsored or endorsed by ASCO or The ASCO Foundation.
| Event Date |
Details |
| Saturday, May 31, 2008 |
6:00 PM - 8:30 PM
Local Time
6:00 PM - 6:30 PM Registration and Dinner
6:30 PM - 8:30 PM Symposium
|
Agenda
6:30 PM – 6:40 PM Welcome and Introduction
Ezra E. W. Cohen, MD, FRCPC
6:40 PM – 7:05 PM Targeting Multiple Pathways in the Treatment of Cancer
Manuel Hidalgo, MD, PhD
7:05 PM – 7:30 PM EGFR-Targeted Antibodies: Clinical Applications, Treatment Challenges, and Ongoing Scientific Research
David Cunningham, MD, FRCP
7:30 PM – 7:55 PM Multitargeted Tyrosine Kinase Inhibitors: Clinical Advances, Synergistic Approaches, and Future Development
Ezra E. W. Cohen, MD, FRCPC
7:55 PM – 8:20 PM Targeting the Tumor Microenvironment: Ongoing Research, Clinical Updates and Promising Applications
Allan Lipton, MD
8:20 PM – 8:30 PM Discussion Panel and Audience Question and Answer Session
Faculty Members